文献速递临床试验与 GCP流行病学与生物统计

针对症状性不稳定脊柱转移瘤患者在一次住院期间行立体定向体部放疗与椎弓根螺钉固定的随机试验(BLEND RCT),采用队列内试验(TwiCs)设计

Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design.
PubMed 文献 · Trials · 2023-05-04

BLEND RCT是一项III期随机对照试验,嵌套于PRESENT队列,采用TwiCs设计,纳入需稳定手术和放疗的症状性不稳定脊柱转移瘤患者。干预组(n=50)可接受同日SBRT与手术,对照组(n=50)不知情并接受标准治疗(手术后1-2周伤口愈合允许时行常规放疗)。主要结局为治疗开始后4周的身体功能(EORTC-QLQ-C15-PAL),次要结局包括疼痛反应、恢复全身肿瘤治疗时间、生活质量、局部肿瘤控制及治疗后3个月内的不良事件。

要点

  • BLEND RCT评估同日SBRT与稳定手术对比标准治疗对症状性不稳定脊柱转移瘤的效果。
  • 主要结局为治疗开始后4周的身体功能(EORTC-QLQ-C15-PAL)。
  • 采用TwiCs设计,对照组不知情,以预防失望偏倚和脱落。

核心结论

  • BLEND RCT评估同日SBRT与稳定手术对比标准治疗症状性不稳定脊柱转移瘤的效果,预期功能结局更好、疼痛缓解更快且能继续全身肿瘤治疗。

研究设计与样本

  • III期随机对照试验,嵌套于PRESENT队列,采用TwiCs设计,按1:1随机分组。
  • 干预组(n=50)可接受同日SBRT与手术,可拒绝;对照组(n=50)不知情并接受标准治疗(手术后1-2周伤口愈合允许时行常规放疗)。

主要发现

  • 原文未报告结果。

关键数值与推荐

  • 主要结局为治疗开始后4周的身体功能(EORTC-QLQ-C15-PAL)。
  • 次要结局包括疼痛反应、恢复全身肿瘤治疗时间、生活质量、局部肿瘤控制及治疗后3个月内的不良事件。
  • SBRT后24小时内手术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spinal metastases can lead to unremitting pain and neurological deficits, which substantially impair daily functioning and quality of life. Patients with unstable spinal metastases receive surgical stabilization followed by palliative radiotherapy as soon as wound healing allows. The time between surgery and radiotherapy delays improvement of mobility, radiotherapy-induced pain relief, local tumor control, and restart of systemic oncological therapy. Stereotactic body radiotherapy (SBRT) enables delivery of preoperative high-dose radiotherapy while dose-sparing the surgical field, allowing stabilizing surgery within only hours. Patients may experience earlier recovery of mobility, regression of pain, and return to systemic oncological therapy. The BLEND RCT evaluates the effectiveness of SBRT followed by surgery within 24 h for the treatment of symptomatic, unstable spinal metastases. METHODS: This phase III randomized controlled trial is embedded within the PRospective Evaluation of interventional StudiEs on boNe meTastases (PRESENT) cohort. Patients with symptomatic, unstable spinal metastases requiring stabilizing surgery and radiotherapy will be randomized (1:1). The intervention group (n = 50) will be offered same-day SBRT and surgery, which they can accept or refuse. According to the Trial within Cohorts (TwiCs) design, the control group (n = 50) will not be informed and receive standard treatment (surgery followed by conventional radiotherapy after 1-2 weeks when wound healing allows). Baseline characteristics and outcome measures will be captured within PRESENT. The primary outcome is physical functioning (EORTC-QLQ-C15-PAL) 4 weeks after start of treatment. Secondary endpoints include pain response, time until return to systemic oncological therapy, quality of life, local tumor control, and adverse events up to 3 months post-treatment. DISCUSSION: The BLEND RCT evaluates the effect of same-day SBRT and stabilizing surgery for the treatment of symptomatic, unstable spinal metastases compared with standard of care. We expect better functional outcomes, faster pain relief, and continuation of systemic oncological therapy. The TwiCs design enables efficient recruitment within an ongoing cohort, as well as prevention of disappointment bias and drop-out as control patients will not be informed about the trial. TRIAL REGISTRATION: ClinicalTrials.gov NCT05575323. Registered on October 11, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Huele EH, van der Velden JM, Kasperts N, et al. Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design. Trials. 2023. PMID: 37143158. doi:10.1186/s13063-023-07315-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。